nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—L-DOPA—Melphalan—breast cancer	0.319	1	CrCrCtD
Norepinephrine—SLC22A3—Melphalan—breast cancer	0.163	0.474	CbGbCtD
Norepinephrine—SLC22A3—Irinotecan—breast cancer	0.055	0.16	CbGbCtD
Norepinephrine—CYP1A2—Anastrozole—breast cancer	0.0387	0.113	CbGbCtD
Norepinephrine—CYP1A2—Toremifene—breast cancer	0.0354	0.103	CbGbCtD
Norepinephrine—SLC22A2—Vinblastine—breast cancer	0.029	0.0844	CbGbCtD
Norepinephrine—CYP1A2—Tamoxifen—breast cancer	0.0129	0.0376	CbGbCtD
Norepinephrine—CYP1A2—Fluorouracil—breast cancer	0.00952	0.0277	CbGbCtD
Norepinephrine—Injection site necrosis—Gemcitabine—breast cancer	0.00782	0.066	CcSEcCtD
Norepinephrine—Hypovolaemia—Ixabepilone—breast cancer	0.00597	0.0504	CcSEcCtD
Norepinephrine—Gangrene—Gemcitabine—breast cancer	0.00375	0.0317	CcSEcCtD
Norepinephrine—Extravasation—Carboplatin—breast cancer	0.00299	0.0252	CcSEcCtD
Norepinephrine—Hypovolaemia—Irinotecan—breast cancer	0.00271	0.0229	CcSEcCtD
Norepinephrine—SLC18A1—adrenal gland—breast cancer	0.00221	0.0523	CbGeAlD
Norepinephrine—SLC18A1—endocrine gland—breast cancer	0.00191	0.0453	CbGeAlD
Norepinephrine—Extravasation—Idarubicin—breast cancer	0.0019	0.016	CcSEcCtD
Norepinephrine—Blood pressure increased—Raloxifene—breast cancer	0.00165	0.014	CcSEcCtD
Norepinephrine—Lactic acidosis—Epirubicin—breast cancer	0.00161	0.0136	CcSEcCtD
Norepinephrine—Lactic acidosis—Doxorubicin—breast cancer	0.00149	0.0126	CcSEcCtD
Norepinephrine—Extravasation—Vinblastine—breast cancer	0.00141	0.0119	CcSEcCtD
Norepinephrine—ADRB3—adipose tissue—breast cancer	0.00138	0.0327	CbGeAlD
Norepinephrine—PAH—endocrine gland—breast cancer	0.00137	0.0325	CbGeAlD
Norepinephrine—Extravasation—Melphalan—breast cancer	0.00134	0.0113	CcSEcCtD
Norepinephrine—SLC18A1—lymph node—breast cancer	0.00132	0.0313	CbGeAlD
Norepinephrine—Extravasation—Goserelin—breast cancer	0.00131	0.011	CcSEcCtD
Norepinephrine—Anxiety—Fluoxymesterone—breast cancer	0.00128	0.0108	CcSEcCtD
Norepinephrine—ADRB3—female reproductive system—breast cancer	0.00127	0.03	CbGeAlD
Norepinephrine—Sweating—Fulvestrant—breast cancer	0.00121	0.0102	CcSEcCtD
Norepinephrine—Sweating—Toremifene—breast cancer	0.0012	0.0101	CcSEcCtD
Norepinephrine—Extravasation—Vinorelbine—breast cancer	0.00117	0.00988	CcSEcCtD
Norepinephrine—ADRB3—female gonad—breast cancer	0.00115	0.0273	CbGeAlD
Norepinephrine—Photophobia—Vinblastine—breast cancer	0.00115	0.00973	CcSEcCtD
Norepinephrine—Extravasation—Thiotepa—breast cancer	0.00112	0.00943	CcSEcCtD
Norepinephrine—Sweating—Exemestane—breast cancer	0.00105	0.00888	CcSEcCtD
Norepinephrine—SLC22A3—nipple—breast cancer	0.00103	0.0244	CbGeAlD
Norepinephrine—Arrhythmia—Toremifene—breast cancer	0.001	0.00844	CcSEcCtD
Norepinephrine—Retrosternal pain—Epirubicin—breast cancer	0.000974	0.00823	CcSEcCtD
Norepinephrine—Extravasation—Irinotecan—breast cancer	0.000965	0.00814	CcSEcCtD
Norepinephrine—Extravasation—Mitoxantrone—breast cancer	0.000965	0.00814	CcSEcCtD
Norepinephrine—ADRA1D—epithelium—breast cancer	0.00096	0.0228	CbGeAlD
Norepinephrine—Extravasation—Gemcitabine—breast cancer	0.00094	0.00793	CcSEcCtD
Norepinephrine—Sweating—Letrozole—breast cancer	0.000935	0.00789	CcSEcCtD
Norepinephrine—Sweating—Anastrozole—breast cancer	0.000935	0.00789	CcSEcCtD
Norepinephrine—Extravasation—Fluorouracil—breast cancer	0.000924	0.0078	CcSEcCtD
Norepinephrine—Photophobia—Thiotepa—breast cancer	0.000915	0.00773	CcSEcCtD
Norepinephrine—SLC22A5—mammary gland—breast cancer	0.000904	0.0214	CbGeAlD
Norepinephrine—Retrosternal pain—Doxorubicin—breast cancer	0.000901	0.00761	CcSEcCtD
Norepinephrine—Sweating—Raloxifene—breast cancer	0.000887	0.00749	CcSEcCtD
Norepinephrine—SLC18A2—endometrium—breast cancer	0.000872	0.0207	CbGeAlD
Norepinephrine—SLC22A3—embryo—breast cancer	0.000848	0.0201	CbGeAlD
Norepinephrine—Chest pain—Fulvestrant—breast cancer	0.000841	0.0071	CcSEcCtD
Norepinephrine—Anxiety—Fulvestrant—breast cancer	0.000838	0.00707	CcSEcCtD
Norepinephrine—Chest pain—Toremifene—breast cancer	0.00083	0.00701	CcSEcCtD
Norepinephrine—Methyldopa—COMT—breast cancer	0.000827	0.353	CrCbGaD
Norepinephrine—SLC18A2—uterus—breast cancer	0.000803	0.019	CbGeAlD
Norepinephrine—Extravasation—Paclitaxel—breast cancer	0.000787	0.00664	CcSEcCtD
Norepinephrine—SLC18A2—adipose tissue—breast cancer	0.000786	0.0186	CbGeAlD
Norepinephrine—Dyspnoea—Lapatinib—breast cancer	0.000781	0.0066	CcSEcCtD
Norepinephrine—ADRA2C—nipple—breast cancer	0.000781	0.0185	CbGeAlD
Norepinephrine—Hyperhidrosis—Fulvestrant—breast cancer	0.000779	0.00658	CcSEcCtD
Norepinephrine—Headache—Fluoxymesterone—breast cancer	0.000773	0.00653	CcSEcCtD
Norepinephrine—Hyperhidrosis—Toremifene—breast cancer	0.000769	0.00649	CcSEcCtD
Norepinephrine—Photophobia—Fluorouracil—breast cancer	0.000757	0.00639	CcSEcCtD
Norepinephrine—SLC22A5—nipple—breast cancer	0.000748	0.0177	CbGeAlD
Norepinephrine—Arrhythmia—Idarubicin—breast cancer	0.000742	0.00627	CcSEcCtD
Norepinephrine—Hypertension—Exemestane—breast cancer	0.00074	0.00625	CcSEcCtD
Norepinephrine—Chest pain—Exemestane—breast cancer	0.00073	0.00617	CcSEcCtD
Norepinephrine—Anxiety—Exemestane—breast cancer	0.000728	0.00614	CcSEcCtD
Norepinephrine—SLC18A2—female reproductive system—breast cancer	0.000722	0.0171	CbGeAlD
Norepinephrine—Dyspnoea—Fulvestrant—breast cancer	0.000718	0.00607	CcSEcCtD
Norepinephrine—ADRA1D—female reproductive system—breast cancer	0.000713	0.0169	CbGeAlD
Norepinephrine—Dyspnoea—Toremifene—breast cancer	0.000709	0.00599	CcSEcCtD
Norepinephrine—SLC18A2—adrenal gland—breast cancer	0.000705	0.0167	CbGeAlD
Norepinephrine—Chest pain—Ixabepilone—breast cancer	0.000689	0.00582	CcSEcCtD
Norepinephrine—Blood pressure increased—Paclitaxel—breast cancer	0.000686	0.0058	CcSEcCtD
Norepinephrine—CYP1A2—nipple—breast cancer	0.000677	0.016	CbGeAlD
Norepinephrine—Hyperhidrosis—Exemestane—breast cancer	0.000677	0.00571	CcSEcCtD
Norepinephrine—Extravasation—Docetaxel—breast cancer	0.000667	0.00563	CcSEcCtD
Norepinephrine—Hypertension—Letrozole—breast cancer	0.000658	0.00556	CcSEcCtD
Norepinephrine—Hypertension—Anastrozole—breast cancer	0.000658	0.00556	CcSEcCtD
Norepinephrine—Chest pain—Letrozole—breast cancer	0.000649	0.00548	CcSEcCtD
Norepinephrine—Chest pain—Anastrozole—breast cancer	0.000649	0.00548	CcSEcCtD
Norepinephrine—Anxiety—Anastrozole—breast cancer	0.000647	0.00546	CcSEcCtD
Norepinephrine—Anxiety—Letrozole—breast cancer	0.000647	0.00546	CcSEcCtD
Norepinephrine—Sweating—Tamoxifen—breast cancer	0.00064	0.0054	CcSEcCtD
Norepinephrine—Dyspnoea—Exemestane—breast cancer	0.000624	0.00527	CcSEcCtD
Norepinephrine—ADRA2A—nipple—breast cancer	0.000623	0.0148	CbGeAlD
Norepinephrine—SLC22A3—endometrium—breast cancer	0.000621	0.0147	CbGeAlD
Norepinephrine—Chest pain—Raloxifene—breast cancer	0.000616	0.0052	CcSEcCtD
Norepinephrine—Chest pain—Idarubicin—breast cancer	0.000616	0.0052	CcSEcCtD
Norepinephrine—SLC18A2—endocrine gland—breast cancer	0.000611	0.0145	CbGeAlD
Norepinephrine—Sweating—Goserelin—breast cancer	0.000611	0.00516	CcSEcCtD
Norepinephrine—ADRA1D—endocrine gland—breast cancer	0.000604	0.0143	CbGeAlD
Norepinephrine—Hyperhidrosis—Anastrozole—breast cancer	0.000601	0.00508	CcSEcCtD
Norepinephrine—Hyperhidrosis—Letrozole—breast cancer	0.000601	0.00508	CcSEcCtD
Norepinephrine—Dyspnoea—Ixabepilone—breast cancer	0.000589	0.00497	CcSEcCtD
Norepinephrine—SLC22A1—adipose tissue—breast cancer	0.000585	0.0139	CbGeAlD
Norepinephrine—Blood pressure increased—Docetaxel—breast cancer	0.000582	0.00491	CcSEcCtD
Norepinephrine—Hyperhidrosis—Raloxifene—breast cancer	0.000571	0.00482	CcSEcCtD
Norepinephrine—ADRB1—adipose tissue—breast cancer	0.000564	0.0134	CbGeAlD
Norepinephrine—Blood pressure increased—Capecitabine—breast cancer	0.000563	0.00476	CcSEcCtD
Norepinephrine—SLC22A3—adipose tissue—breast cancer	0.000559	0.0133	CbGeAlD
Norepinephrine—Vomiting—Lapatinib—breast cancer	0.000557	0.0047	CcSEcCtD
Norepinephrine—Dyspnoea—Anastrozole—breast cancer	0.000554	0.00468	CcSEcCtD
Norepinephrine—Dyspnoea—Letrozole—breast cancer	0.000554	0.00468	CcSEcCtD
Norepinephrine—ADRA1A—epithelium—breast cancer	0.000551	0.0131	CbGeAlD
Norepinephrine—Headache—Lapatinib—breast cancer	0.000549	0.00464	CcSEcCtD
Norepinephrine—Arrhythmia—Tamoxifen—breast cancer	0.000535	0.00452	CcSEcCtD
Norepinephrine—Arrhythmia—Melphalan—breast cancer	0.000524	0.00442	CcSEcCtD
Norepinephrine—ADRB1—female reproductive system—breast cancer	0.000518	0.0123	CbGeAlD
Norepinephrine—SLC22A3—female reproductive system—breast cancer	0.000514	0.0122	CbGeAlD
Norepinephrine—Vomiting—Fulvestrant—breast cancer	0.000512	0.00433	CcSEcCtD
Norepinephrine—Arrhythmia—Goserelin—breast cancer	0.000511	0.00432	CcSEcCtD
Norepinephrine—Vomiting—Toremifene—breast cancer	0.000506	0.00427	CcSEcCtD
Norepinephrine—Headache—Fulvestrant—breast cancer	0.000505	0.00426	CcSEcCtD
Norepinephrine—SLC22A3—adrenal gland—breast cancer	0.000502	0.0119	CbGeAlD
Norepinephrine—Headache—Toremifene—breast cancer	0.000498	0.00421	CcSEcCtD
Norepinephrine—Extravasation—Methotrexate—breast cancer	0.000481	0.00406	CcSEcCtD
Norepinephrine—SLC22A5—skin of body—breast cancer	0.000479	0.0113	CbGeAlD
Norepinephrine—ADRA2C—endometrium—breast cancer	0.000471	0.0112	CbGeAlD
Norepinephrine—SLC22A3—female gonad—breast cancer	0.000468	0.0111	CbGeAlD
Norepinephrine—Hypertension—Vinblastine—breast cancer	0.000463	0.00391	CcSEcCtD
Norepinephrine—Arrhythmia—Vinorelbine—breast cancer	0.000458	0.00387	CcSEcCtD
Norepinephrine—SLC22A1—endocrine gland—breast cancer	0.000455	0.0108	CbGeAlD
Norepinephrine—SLC22A5—endometrium—breast cancer	0.000451	0.0107	CbGeAlD
Norepinephrine—Sweating—Mitoxantrone—breast cancer	0.000451	0.00381	CcSEcCtD
Norepinephrine—Sweating—Irinotecan—breast cancer	0.000451	0.00381	CcSEcCtD
Norepinephrine—Hypertension—Tamoxifen—breast cancer	0.00045	0.0038	CcSEcCtD
Norepinephrine—Extravasation—Epirubicin—breast cancer	0.00045	0.0038	CcSEcCtD
Norepinephrine—ADRA1A—adipose tissue—breast cancer	0.000446	0.0106	CbGeAlD
Norepinephrine—Vomiting—Exemestane—breast cancer	0.000445	0.00376	CcSEcCtD
Norepinephrine—Chest pain—Tamoxifen—breast cancer	0.000444	0.00375	CcSEcCtD
Norepinephrine—Anxiety—Tamoxifen—breast cancer	0.000442	0.00374	CcSEcCtD
Norepinephrine—SLC6A2—female reproductive system—breast cancer	0.000441	0.0104	CbGeAlD
Norepinephrine—Sweating—Gemcitabine—breast cancer	0.00044	0.00371	CcSEcCtD
Norepinephrine—DRD2—pituitary gland—breast cancer	0.000439	0.0104	CbGeAlD
Norepinephrine—Headache—Exemestane—breast cancer	0.000438	0.0037	CcSEcCtD
Norepinephrine—ADRB1—endocrine gland—breast cancer	0.000438	0.0104	CbGeAlD
Norepinephrine—Arrhythmia—Thiotepa—breast cancer	0.000437	0.00369	CcSEcCtD
Norepinephrine—SLC22A3—endocrine gland—breast cancer	0.000435	0.0103	CbGeAlD
Norepinephrine—Chest pain—Melphalan—breast cancer	0.000435	0.00367	CcSEcCtD
Norepinephrine—ADRA2C—uterus—breast cancer	0.000434	0.0103	CbGeAlD
Norepinephrine—Bradycardia—Irinotecan—breast cancer	0.00043	0.00363	CcSEcCtD
Norepinephrine—Bradycardia—Mitoxantrone—breast cancer	0.00043	0.00363	CcSEcCtD
Norepinephrine—SLC6A2—adrenal gland—breast cancer	0.00043	0.0102	CbGeAlD
Norepinephrine—Hypertension—Goserelin—breast cancer	0.00043	0.00363	CcSEcCtD
Norepinephrine—ADRA2C—pituitary gland—breast cancer	0.000426	0.0101	CbGeAlD
Norepinephrine—ADRA2C—adipose tissue—breast cancer	0.000425	0.0101	CbGeAlD
Norepinephrine—Chest pain—Goserelin—breast cancer	0.000424	0.00358	CcSEcCtD
Norepinephrine—Anxiety—Goserelin—breast cancer	0.000423	0.00357	CcSEcCtD
Norepinephrine—SLC18A2—lymph node—breast cancer	0.000422	0.01	CbGeAlD
Norepinephrine—Vomiting—Ixabepilone—breast cancer	0.00042	0.00355	CcSEcCtD
Norepinephrine—Extravasation—Doxorubicin—breast cancer	0.000416	0.00351	CcSEcCtD
Norepinephrine—Headache—Ixabepilone—breast cancer	0.000414	0.00349	CcSEcCtD
Norepinephrine—Hyperhidrosis—Tamoxifen—breast cancer	0.000411	0.00347	CcSEcCtD
Norepinephrine—SLC22A5—pituitary gland—breast cancer	0.000408	0.00968	CbGeAlD
Norepinephrine—SLC22A5—adipose tissue—breast cancer	0.000407	0.00964	CbGeAlD
Norepinephrine—Dopamine—COMT—breast cancer	0.000404	0.172	CrCbGaD
Norepinephrine—ADRA1A—adrenal gland—breast cancer	0.0004	0.00947	CbGeAlD
Norepinephrine—Vomiting—Letrozole—breast cancer	0.000395	0.00334	CcSEcCtD
Norepinephrine—Vomiting—Anastrozole—breast cancer	0.000395	0.00334	CcSEcCtD
Norepinephrine—Hyperhidrosis—Goserelin—breast cancer	0.000393	0.00332	CcSEcCtD
Norepinephrine—Headache—Anastrozole—breast cancer	0.00039	0.00329	CcSEcCtD
Norepinephrine—Headache—Letrozole—breast cancer	0.00039	0.00329	CcSEcCtD
Norepinephrine—Hypertension—Vinorelbine—breast cancer	0.000385	0.00325	CcSEcCtD
Norepinephrine—ADRA2C—adrenal gland—breast cancer	0.000381	0.00903	CbGeAlD
Norepinephrine—Chest pain—Vinorelbine—breast cancer	0.00038	0.00321	CcSEcCtD
Norepinephrine—Dyspnoea—Tamoxifen—breast cancer	0.000379	0.0032	CcSEcCtD
Norepinephrine—Arrhythmia—Mitoxantrone—breast cancer	0.000378	0.00319	CcSEcCtD
Norepinephrine—Arrhythmia—Irinotecan—breast cancer	0.000378	0.00319	CcSEcCtD
Norepinephrine—ADRA2A—endometrium—breast cancer	0.000376	0.00891	CbGeAlD
Norepinephrine—Vomiting—Idarubicin—breast cancer	0.000375	0.00317	CcSEcCtD
Norepinephrine—Vomiting—Raloxifene—breast cancer	0.000375	0.00317	CcSEcCtD
Norepinephrine—SLC22A5—female reproductive system—breast cancer	0.000374	0.00886	CbGeAlD
Norepinephrine—SLC6A2—endocrine gland—breast cancer	0.000373	0.00884	CbGeAlD
Norepinephrine—Dyspnoea—Melphalan—breast cancer	0.000372	0.00314	CcSEcCtD
Norepinephrine—Headache—Raloxifene—breast cancer	0.00037	0.00312	CcSEcCtD
Norepinephrine—Headache—Idarubicin—breast cancer	0.00037	0.00312	CcSEcCtD
Norepinephrine—Hypertension—Thiotepa—breast cancer	0.000368	0.00311	CcSEcCtD
Norepinephrine—Arrhythmia—Gemcitabine—breast cancer	0.000368	0.00311	CcSEcCtD
Norepinephrine—SLC22A5—adrenal gland—breast cancer	0.000365	0.00865	CbGeAlD
Norepinephrine—Dyspnoea—Goserelin—breast cancer	0.000362	0.00306	CcSEcCtD
Norepinephrine—Arrhythmia—Fluorouracil—breast cancer	0.000362	0.00305	CcSEcCtD
Norepinephrine—Anxiety—Thiotepa—breast cancer	0.000361	0.00305	CcSEcCtD
Norepinephrine—ADRA2C—female gonad—breast cancer	0.000355	0.00842	CbGeAlD
Norepinephrine—Bradycardia—Paclitaxel—breast cancer	0.000351	0.00296	CcSEcCtD
Norepinephrine—ADRA1A—endocrine gland—breast cancer	0.000347	0.00821	CbGeAlD
Norepinephrine—ADRA2A—uterus—breast cancer	0.000347	0.00821	CbGeAlD
Norepinephrine—ADRA2A—pituitary gland—breast cancer	0.00034	0.00806	CbGeAlD
Norepinephrine—SLC22A5—female gonad—breast cancer	0.00034	0.00806	CbGeAlD
Norepinephrine—DRD2—endocrine gland—breast cancer	0.00034	0.00805	CbGeAlD
Norepinephrine—ADRA2A—adipose tissue—breast cancer	0.000339	0.00803	CbGeAlD
Norepinephrine—Dyspnoea—Vinorelbine—breast cancer	0.000325	0.00274	CcSEcCtD
Norepinephrine—Hypertension—Irinotecan—breast cancer	0.000318	0.00268	CcSEcCtD
Norepinephrine—Hypertension—Mitoxantrone—breast cancer	0.000318	0.00268	CcSEcCtD
Norepinephrine—Chest pain—Mitoxantrone—breast cancer	0.000313	0.00264	CcSEcCtD
Norepinephrine—Anxiety—Mitoxantrone—breast cancer	0.000312	0.00264	CcSEcCtD
Norepinephrine—ADRA2A—female reproductive system—breast cancer	0.000312	0.00738	CbGeAlD
Norepinephrine—Hypertension—Gemcitabine—breast cancer	0.000309	0.00261	CcSEcCtD
Norepinephrine—Arrhythmia—Paclitaxel—breast cancer	0.000308	0.0026	CcSEcCtD
Norepinephrine—Chest pain—Gemcitabine—breast cancer	0.000305	0.00258	CcSEcCtD
Norepinephrine—ADRA2A—adrenal gland—breast cancer	0.000304	0.0072	CbGeAlD
Norepinephrine—Vomiting—Chlorambucil—breast cancer	0.000304	0.00257	CcSEcCtD
Norepinephrine—SLC22A3—lymph node—breast cancer	0.000301	0.00713	CbGeAlD
Norepinephrine—Chest pain—Fluorouracil—breast cancer	0.0003	0.00253	CcSEcCtD
Norepinephrine—Hyperhidrosis—Mitoxantrone—breast cancer	0.00029	0.00245	CcSEcCtD
Norepinephrine—Hyperhidrosis—Irinotecan—breast cancer	0.00029	0.00245	CcSEcCtD
Norepinephrine—Bradycardia—Capecitabine—breast cancer	0.000288	0.00243	CcSEcCtD
Norepinephrine—CYP1A2—endocrine gland—breast cancer	0.000287	0.00679	CbGeAlD
Norepinephrine—ADRA2A—female gonad—breast cancer	0.000283	0.00672	CbGeAlD
Norepinephrine—Hyperhidrosis—Gemcitabine—breast cancer	0.000283	0.00239	CcSEcCtD
Norepinephrine—Vomiting—Vinblastine—breast cancer	0.000279	0.00235	CcSEcCtD
Norepinephrine—Headache—Vinblastine—breast cancer	0.000274	0.00232	CcSEcCtD
Norepinephrine—Vomiting—Tamoxifen—breast cancer	0.000271	0.00228	CcSEcCtD
Norepinephrine—Dyspnoea—Irinotecan—breast cancer	0.000268	0.00226	CcSEcCtD
Norepinephrine—Dyspnoea—Mitoxantrone—breast cancer	0.000268	0.00226	CcSEcCtD
Norepinephrine—Headache—Tamoxifen—breast cancer	0.000267	0.00225	CcSEcCtD
Norepinephrine—Vomiting—Melphalan—breast cancer	0.000265	0.00224	CcSEcCtD
Norepinephrine—ADRA2A—endocrine gland—breast cancer	0.000264	0.00625	CbGeAlD
Norepinephrine—Arrhythmia—Docetaxel—breast cancer	0.000261	0.0022	CcSEcCtD
Norepinephrine—Dyspnoea—Gemcitabine—breast cancer	0.000261	0.0022	CcSEcCtD
Norepinephrine—Hypertension—Paclitaxel—breast cancer	0.000259	0.00219	CcSEcCtD
Norepinephrine—Vomiting—Goserelin—breast cancer	0.000258	0.00218	CcSEcCtD
Norepinephrine—SLC6A2—lymph node—breast cancer	0.000258	0.00611	CbGeAlD
Norepinephrine—Dyspnoea—Fluorouracil—breast cancer	0.000256	0.00216	CcSEcCtD
Norepinephrine—Salbutamol—CYP3A4—breast cancer	0.000256	0.109	CrCbGaD
Norepinephrine—Chest pain—Paclitaxel—breast cancer	0.000255	0.00216	CcSEcCtD
Norepinephrine—Headache—Goserelin—breast cancer	0.000255	0.00215	CcSEcCtD
Norepinephrine—Anxiety—Paclitaxel—breast cancer	0.000255	0.00215	CcSEcCtD
Norepinephrine—Arrhythmia—Capecitabine—breast cancer	0.000253	0.00213	CcSEcCtD
Norepinephrine—Epinephrine—TNF—breast cancer	0.000238	0.102	CrCbGaD
Norepinephrine—Hyperhidrosis—Paclitaxel—breast cancer	0.000237	0.002	CcSEcCtD
Norepinephrine—Vomiting—Vinorelbine—breast cancer	0.000231	0.00195	CcSEcCtD
Norepinephrine—ADRA2C—lymph node—breast cancer	0.000228	0.00541	CbGeAlD
Norepinephrine—Headache—Vinorelbine—breast cancer	0.000228	0.00193	CcSEcCtD
Norepinephrine—Sweating—Methotrexate—breast cancer	0.000225	0.0019	CcSEcCtD
Norepinephrine—Vomiting—Thiotepa—breast cancer	0.000221	0.00187	CcSEcCtD
Norepinephrine—Hypertension—Docetaxel—breast cancer	0.00022	0.00185	CcSEcCtD
Norepinephrine—SLC22A5—lymph node—breast cancer	0.000219	0.00518	CbGeAlD
Norepinephrine—Dyspnoea—Paclitaxel—breast cancer	0.000218	0.00184	CcSEcCtD
Norepinephrine—Headache—Thiotepa—breast cancer	0.000218	0.00184	CcSEcCtD
Norepinephrine—Chest pain—Docetaxel—breast cancer	0.000217	0.00183	CcSEcCtD
Norepinephrine—Isoprenaline—CYP1A1—breast cancer	0.000216	0.092	CrCbGaD
Norepinephrine—Hypertension—Capecitabine—breast cancer	0.000213	0.0018	CcSEcCtD
Norepinephrine—Sweating—Epirubicin—breast cancer	0.00021	0.00178	CcSEcCtD
Norepinephrine—Chest pain—Capecitabine—breast cancer	0.00021	0.00177	CcSEcCtD
Norepinephrine—Anxiety—Capecitabine—breast cancer	0.000209	0.00176	CcSEcCtD
Norepinephrine—Bradycardia—Epirubicin—breast cancer	0.000201	0.00169	CcSEcCtD
Norepinephrine—Sweating—Doxorubicin—breast cancer	0.000195	0.00164	CcSEcCtD
Norepinephrine—Hyperhidrosis—Capecitabine—breast cancer	0.000194	0.00164	CcSEcCtD
Norepinephrine—Vomiting—Irinotecan—breast cancer	0.000191	0.00161	CcSEcCtD
Norepinephrine—Vomiting—Mitoxantrone—breast cancer	0.000191	0.00161	CcSEcCtD
Norepinephrine—Headache—Mitoxantrone—breast cancer	0.000188	0.00159	CcSEcCtD
Norepinephrine—Headache—Irinotecan—breast cancer	0.000188	0.00159	CcSEcCtD
Norepinephrine—Vomiting—Gemcitabine—breast cancer	0.000186	0.00157	CcSEcCtD
Norepinephrine—Bradycardia—Doxorubicin—breast cancer	0.000186	0.00157	CcSEcCtD
Norepinephrine—Dyspnoea—Docetaxel—breast cancer	0.000185	0.00156	CcSEcCtD
Norepinephrine—Headache—Gemcitabine—breast cancer	0.000183	0.00155	CcSEcCtD
Norepinephrine—Vomiting—Fluorouracil—breast cancer	0.000183	0.00154	CcSEcCtD
Norepinephrine—ADRA2A—lymph node—breast cancer	0.000182	0.00432	CbGeAlD
Norepinephrine—Headache—Fluorouracil—breast cancer	0.00018	0.00152	CcSEcCtD
Norepinephrine—Dyspnoea—Capecitabine—breast cancer	0.000179	0.00151	CcSEcCtD
Norepinephrine—Arrhythmia—Epirubicin—breast cancer	0.000176	0.00149	CcSEcCtD
Norepinephrine—Arrhythmia—Doxorubicin—breast cancer	0.000163	0.00138	CcSEcCtD
Norepinephrine—Chest pain—Methotrexate—breast cancer	0.000156	0.00132	CcSEcCtD
Norepinephrine—Vomiting—Paclitaxel—breast cancer	0.000156	0.00131	CcSEcCtD
Norepinephrine—Headache—Paclitaxel—breast cancer	0.000153	0.0013	CcSEcCtD
Norepinephrine—L-DOPA—CYP2D6—breast cancer	0.000149	0.0634	CrCbGaD
Norepinephrine—Hypertension—Epirubicin—breast cancer	0.000148	0.00125	CcSEcCtD
Norepinephrine—Chest pain—Epirubicin—breast cancer	0.000146	0.00123	CcSEcCtD
Norepinephrine—Anxiety—Epirubicin—breast cancer	0.000146	0.00123	CcSEcCtD
Norepinephrine—Hyperhidrosis—Methotrexate—breast cancer	0.000145	0.00122	CcSEcCtD
Norepinephrine—Dopamine—CYP2D6—breast cancer	0.000138	0.0589	CrCbGaD
Norepinephrine—Hypertension—Doxorubicin—breast cancer	0.000137	0.00116	CcSEcCtD
Norepinephrine—Hyperhidrosis—Epirubicin—breast cancer	0.000135	0.00114	CcSEcCtD
Norepinephrine—Chest pain—Doxorubicin—breast cancer	0.000135	0.00114	CcSEcCtD
Norepinephrine—Anxiety—Doxorubicin—breast cancer	0.000135	0.00114	CcSEcCtD
Norepinephrine—Dyspnoea—Methotrexate—breast cancer	0.000133	0.00113	CcSEcCtD
Norepinephrine—Vomiting—Docetaxel—breast cancer	0.000132	0.00111	CcSEcCtD
Norepinephrine—Headache—Docetaxel—breast cancer	0.00013	0.0011	CcSEcCtD
Norepinephrine—Vomiting—Capecitabine—breast cancer	0.000128	0.00108	CcSEcCtD
Norepinephrine—Headache—Capecitabine—breast cancer	0.000126	0.00106	CcSEcCtD
Norepinephrine—Hyperhidrosis—Doxorubicin—breast cancer	0.000125	0.00106	CcSEcCtD
Norepinephrine—Dyspnoea—Epirubicin—breast cancer	0.000125	0.00105	CcSEcCtD
Norepinephrine—Epinephrine—CYP3A4—breast cancer	0.000116	0.0493	CrCbGaD
Norepinephrine—Dyspnoea—Doxorubicin—breast cancer	0.000115	0.000975	CcSEcCtD
Norepinephrine—Vomiting—Methotrexate—breast cancer	9.51e-05	0.000803	CcSEcCtD
Norepinephrine—Headache—Methotrexate—breast cancer	9.37e-05	0.000791	CcSEcCtD
Norepinephrine—Vomiting—Epirubicin—breast cancer	8.9e-05	0.000752	CcSEcCtD
Norepinephrine—Headache—Epirubicin—breast cancer	8.77e-05	0.000741	CcSEcCtD
Norepinephrine—Vomiting—Doxorubicin—breast cancer	8.24e-05	0.000695	CcSEcCtD
Norepinephrine—Headache—Doxorubicin—breast cancer	8.12e-05	0.000685	CcSEcCtD
Norepinephrine—ADRB1—Signaling Pathways—CDKN1A—breast cancer	2.13e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PTEN—breast cancer	2.13e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MDM2—breast cancer	2.12e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	2.12e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—breast cancer	2.12e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RAF1—breast cancer	2.12e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—breast cancer	2.11e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN1A—breast cancer	2.11e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—breast cancer	2.11e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RELA—breast cancer	2.11e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PTEN—breast cancer	2.11e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	2.1e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	2.1e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	2.1e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—breast cancer	2.09e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ERBB2—breast cancer	2.09e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—breast cancer	2.09e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2—breast cancer	2.09e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—breast cancer	2.09e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN1A—breast cancer	2.08e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—breast cancer	2.08e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	2.08e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK8—breast cancer	2.08e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PTEN—breast cancer	2.08e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—KRAS—breast cancer	2.08e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—breast cancer	2.07e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CB—breast cancer	2.07e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MTOR—breast cancer	2.07e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—breast cancer	2.06e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—breast cancer	2.06e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK8—breast cancer	2.06e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2—breast cancer	2.06e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GPX1—breast cancer	2.06e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—breast cancer	2.06e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	2.05e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—breast cancer	2.05e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MDM2—breast cancer	2.05e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RAF1—breast cancer	2.04e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCND1—breast cancer	2.04e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP1A1—breast cancer	2.03e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK8—breast cancer	2.03e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—JUN—breast cancer	2.03e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RELA—breast cancer	2.03e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—breast cancer	2.03e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CTNNB1—breast cancer	2.02e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ERCC2—breast cancer	2.02e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	2.02e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCND1—breast cancer	2.01e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NOS3—breast cancer	2e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—JUN—breast cancer	2e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MAPK3—breast cancer	1.99e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	1.99e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MTOR—breast cancer	1.99e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	1.99e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL8—breast cancer	1.99e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—breast cancer	1.98e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HRAS—breast cancer	1.97e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1A—breast cancer	1.97e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SRC—breast cancer	1.97e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PTEN—breast cancer	1.97e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SRC—breast cancer	1.95e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—breast cancer	1.95e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	1.94e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1B—breast cancer	1.94e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—breast cancer	1.94e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PTEN—breast cancer	1.94e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—breast cancer	1.93e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SRC—breast cancer	1.93e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK8—breast cancer	1.93e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.92e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—breast cancer	1.92e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—breast cancer	1.92e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	1.91e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTEN—breast cancer	1.91e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	1.91e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—breast cancer	1.9e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—breast cancer	1.9e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.9e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	1.9e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—breast cancer	1.9e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2—breast cancer	1.9e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—MTHFR—breast cancer	1.9e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EGFR—breast cancer	1.9e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK8—breast cancer	1.89e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.89e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—breast cancer	1.89e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—breast cancer	1.89e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RELA—breast cancer	1.89e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—breast cancer	1.88e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—breast cancer	1.88e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.87e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	1.87e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—breast cancer	1.86e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCND1—breast cancer	1.85e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.85e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.85e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	1.85e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—JUN—breast cancer	1.85e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.83e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.83e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2—breast cancer	1.83e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SRC—breast cancer	1.83e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.82e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.82e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.8e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SRC—breast cancer	1.8e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—breast cancer	1.8e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KRAS—breast cancer	1.79e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.79e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PTEN—breast cancer	1.79e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.78e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—JUN—breast cancer	1.78e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.78e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.78e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK3—breast cancer	1.78e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—breast cancer	1.77e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.77e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.77e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.76e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.76e-06	1e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—breast cancer	1.75e-06	9.99e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CAV1—breast cancer	1.75e-06	9.98e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.75e-06	9.98e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK8—breast cancer	1.75e-06	9.97e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.75e-06	9.97e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—breast cancer	1.74e-06	9.94e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.74e-06	9.9e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.73e-06	9.88e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.73e-06	9.87e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—breast cancer	1.73e-06	9.86e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EGFR—breast cancer	1.73e-06	9.86e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.72e-06	9.84e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—breast cancer	1.72e-06	9.84e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.72e-06	9.82e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.72e-06	9.8e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.71e-06	9.77e-06	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PIK3CA—breast cancer	1.71e-06	9.74e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.7e-06	9.71e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2—breast cancer	1.7e-06	9.69e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EGFR—breast cancer	1.69e-06	9.65e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.69e-06	9.64e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.68e-06	9.6e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.68e-06	9.59e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.68e-06	9.58e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.67e-06	9.54e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PIK3CA—breast cancer	1.66e-06	9.47e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.66e-06	9.45e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SRC—breast cancer	1.66e-06	9.45e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.65e-06	9.44e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.65e-06	9.43e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	1.65e-06	9.39e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.64e-06	9.36e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—breast cancer	1.64e-06	9.33e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KRAS—breast cancer	1.63e-06	9.32e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.63e-06	9.31e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.62e-06	9.23e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—breast cancer	1.61e-06	9.2e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—breast cancer	1.61e-06	9.18e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.61e-06	9.17e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.61e-06	9.16e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.6e-06	9.14e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.6e-06	9.13e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.6e-06	9.12e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KRAS—breast cancer	1.6e-06	9.11e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—breast cancer	1.6e-06	9.11e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SRC—breast cancer	1.6e-06	9.1e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.59e-06	9.09e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—breast cancer	1.59e-06	9.09e-06	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PIK3CA—breast cancer	1.59e-06	9.08e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.57e-06	8.98e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.56e-06	8.92e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.56e-06	8.9e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.55e-06	8.87e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.54e-06	8.78e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK3—breast cancer	1.53e-06	8.71e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HRAS—breast cancer	1.52e-06	8.69e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.51e-06	8.62e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PIK3CA—breast cancer	1.5e-06	8.56e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.49e-06	8.49e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.49e-06	8.48e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—breast cancer	1.48e-06	8.47e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SRC—breast cancer	1.48e-06	8.46e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—breast cancer	1.48e-06	8.45e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.47e-06	8.39e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PIK3CA—breast cancer	1.47e-06	8.37e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—breast cancer	1.46e-06	8.32e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EGFR—breast cancer	1.45e-06	8.28e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—breast cancer	1.45e-06	8.28e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.44e-06	8.24e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—breast cancer	1.44e-06	8.2e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—breast cancer	1.43e-06	8.16e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.43e-06	8.16e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.43e-06	8.14e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—breast cancer	1.42e-06	8.1e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.4e-06	7.99e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.4e-06	7.98e-06	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—breast cancer	1.39e-06	7.96e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.39e-06	7.92e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HRAS—breast cancer	1.39e-06	7.92e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—breast cancer	1.38e-06	7.89e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HRAS—breast cancer	1.38e-06	7.85e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KRAS—breast cancer	1.37e-06	7.82e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.37e-06	7.8e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.37e-06	7.79e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HRAS—breast cancer	1.36e-06	7.75e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—breast cancer	1.36e-06	7.74e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CA—breast cancer	1.35e-06	7.69e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—breast cancer	1.34e-06	7.67e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—breast cancer	1.34e-06	7.66e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—breast cancer	1.33e-06	7.58e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—breast cancer	1.33e-06	7.58e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	1.33e-06	7.56e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NOS3—breast cancer	1.32e-06	7.55e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—breast cancer	1.32e-06	7.54e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KRAS—breast cancer	1.32e-06	7.54e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—breast cancer	1.32e-06	7.51e-06	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—breast cancer	1.3e-06	7.42e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—breast cancer	1.3e-06	7.41e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGFR—breast cancer	1.3e-06	7.41e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HRAS—breast cancer	1.28e-06	7.33e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HRAS—breast cancer	1.26e-06	7.21e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CA—breast cancer	1.26e-06	7.19e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—breast cancer	1.23e-06	7.01e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.23e-06	7e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—breast cancer	1.23e-06	6.99e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.22e-06	6.97e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—breast cancer	1.22e-06	6.95e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—breast cancer	1.21e-06	6.93e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.21e-06	6.92e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—breast cancer	1.21e-06	6.9e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—breast cancer	1.21e-06	6.9e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—breast cancer	1.2e-06	6.84e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—breast cancer	1.17e-06	6.7e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HRAS—breast cancer	1.17e-06	6.65e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—breast cancer	1.13e-06	6.47e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.13e-06	6.43e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.12e-06	6.41e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.12e-06	6.37e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—breast cancer	1.12e-06	6.36e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—breast cancer	1.1e-06	6.29e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—breast cancer	1.09e-06	6.22e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—breast cancer	1.07e-06	6.13e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTEN—breast cancer	1.06e-06	6.02e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.04e-06	5.95e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—breast cancer	1.03e-06	5.87e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—breast cancer	9.99e-07	5.7e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—breast cancer	9.91e-07	5.66e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—breast cancer	9.21e-07	5.26e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CA—breast cancer	7.44e-07	4.25e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—breast cancer	6.08e-07	3.47e-06	CbGpPWpGaD
